FCGR3A-eiwit (C-AVI & zijn, mens)

FCGR3A

CD16, CD16-II, CD16A, FCG3, FcgammaRIIIa, FCGR3, FCGRIII, FcGRIIIA, FCR-10, FCRIII, FCRIIIA, IGFR3, IMD20

C-AVI & His

< 1.0 EU per μg of the protein as determined by the LAL method

≥ 95 % as determined by SDS-PAGE, ≥ 95 % as determined by SEC-HPLC, ≥ 95% as determined by SEC-MALS (Routinely tested) .

1. Loaded Recombinant Human CD16a/FCGR3A Protein (F176, His&AVI Tag), Biotinylated (Cat: 10389-H27H-B) on SA Biosensor, can bind anti-VEGFA (Research grade Bevacizumab Biosimilar) with an affinity constant of 0.26 μM as determined in BLI assay (Sartorius Octet RED384) (QC tested) . 2. Loaded anti-CD20 (Research grade Rituximab Biosimilar) on ProA Biosensor, can bind Recombinant Human CD16a/FCGR3A Protein (F176, His&AVI Tag), Biotinylated (Cat: 10389-H27H-B) with an affinity constant of 0.23 μM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested) . 3. Recombinant Human CD16a/FCGR3A Protein (F176, His&AVI Tag), Biotinylated (Cat: 10389-H27H-B) captured on SA chip, can bind anti-CD20 (Research grade Rituximab Biosimilar) with an affinity constant of 0.664 μM as determined in an SPR assay (Biacore 8K) (Routinely tested) .

Met1-Gln208

The secreted recombinant human CD16a consists of 223 amino acids and predicts a molecular mass of 25.1 kDa. By SDS-PAGE under reducing conditions, the apparent molecular mass of the protein is approximately 48 kDa due to glycosylation. The molecular weight of this protein is around 31-47 kDa verified by SEC-MALS (Routinely tested) .

Human